Prostate Cancer Specification
0.1.0 - ci-build
Prostate Cancer Specification
0.1.0 - ci-build
Prostate Cancer Specification - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
{
"resourceType" : "Composition",
"id" : "TransurethralEnucleationComposition",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Composition TransurethralEnucleationComposition</b></p><a name=\"TransurethralEnucleationComposition\"> </a><a name=\"hcTransurethralEnucleationComposition\"> </a><p><b>Document DiagnosticReport Reference</b>: <a href=\"DiagnosticReport-TransurethralEnucleationReport.html\">Diagnostic Report for 'Pathology Synoptic report' for '->Klaus Becker Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)'</a></p><p><b>identifier</b>: Accession ID/PATH-COMP-2024-004</p><p><b>status</b>: Final</p><p><b>type</b>: <span title=\"Codes:{http://loinc.org 11526-1}, {http://ihe-d.de/CodeSystems/IHEXDStypeCode PATH}\">Pathology study</span></p><p><b>encounter</b>: <a href=\"Encounter-TransurethralEnucleationEncounter.html\">Encounter: identifier = http://example.hospital.de/encounters#E_24_004; status = finished; class = IMP (IMP)</a></p><p><b>date</b>: 2024-04-15 08:00:00+0100</p><p><b>author</b>: <a href=\"Organization-PathologyLabOrganization.html\">Pathologisches Institut</a></p><p><b>title</b>: Histopathologischer Befundbericht - Prostata Enucleation</p><h3>Attesters</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Mode</b></td><td><b>Party</b></td></tr><tr><td style=\"display: none\">*</td><td>Legal</td><td><a href=\"Organization-PathologyLabOrganization.html\">Pathologielabor (http://example.hospital.de/organization-ids#ORG-PATH-001)</a></td></tr></table><p><b>custodian</b>: <a href=\"Organization-PathologyLabOrganization.html\">Pathologielabor (http://example.hospital.de/organization-ids#ORG-PATH-001)</a></p><h3>Events</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Period</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://terminology.hl7.org/CodeSystem/v3-ActCode PATREPE}\">pathology report entry task</span></td><td>2024-05-10 10:30:00+0100 --> 2024-05-13 08:00:00+0100</td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.eu/fhir/extensions/StructureDefinition/composition-diagnosticReportReference",
"valueReference" : {
🔗 "reference" : "DiagnosticReport/TransurethralEnucleationReport"
}
}
],
"identifier" : {
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
]
},
"system" : "http://example.hospital.de/pathology-reports",
"value" : "PATH-COMP-2024-004"
},
"status" : "final",
"type" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "11526-1",
"display" : "Pathology study"
},
{
"system" : "http://ihe-d.de/CodeSystems/IHEXDStypeCode",
"code" : "PATH"
}
]
},
"subject" : {
🔗 "reference" : "Patient/Patient3",
"display" : "Klaus Becker, geb. 10.11.1958 (PAT-2024-003)"
},
"encounter" : {
🔗 "reference" : "Encounter/TransurethralEnucleationEncounter"
},
"date" : "2024-04-15T08:00:00+01:00",
"author" : [
{
🔗 "reference" : "Organization/PathologyLabOrganization",
"display" : "Pathologisches Institut"
}
],
"title" : "Histopathologischer Befundbericht - Prostata Enucleation",
"attester" : [
{
"mode" : "legal",
"party" : {
🔗 "reference" : "Organization/PathologyLabOrganization"
}
}
],
"custodian" : {
🔗 "reference" : "Organization/PathologyLabOrganization"
},
"event" : [
{
"code" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ActCode",
"code" : "PATREPE"
}
]
}
],
"period" : {
"start" : "2024-05-10T10:30:00+01:00",
"end" : "2024-05-13T08:00:00+01:00"
}
}
],
"section" : [
{
"title" : "Pathologiebefundbericht",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "60567-5",
"display" : "Comprehensive pathology report panel"
}
]
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h3>Klinische Angaben</h3><p>Obstruktive Miktionsbeschwerden. PSA 12,5 ng/ml. Prostata-Enukleation (HoLEP/ThuLEP). V.a. Prostatakarzinom.</p></div>"
},
"entry" : [
{
🔗 "reference" : "DiagnosticReport/TransurethralEnucleationReport"
}
]
},
{
"title" : "Makroskopie",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "22634-0",
"display" : "Pathology report gross observation Narrative"
}
]
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h3>Makroskopie</h3><p>Enukleationspräparat 25 g, Maße 3,5 × 2,8 × 2,2 cm. Keine Samenblasen, keine Lymphknoten im Resektat.</p><table border=\"1\" cellpadding=\"4\" cellspacing=\"0\"><tbody><tr><td>Präparat</td><td>Prostata-Enukleationspräparat</td></tr><tr><td>Gewicht</td><td>25 g</td></tr><tr><td>Maße (L × B × T)</td><td>3,5 × 2,8 × 2,2 cm</td></tr><tr><td>Samenblasen</td><td>Nicht im Resektat</td></tr><tr><td>Lymphknoten</td><td>Nicht im Resektat</td></tr></tbody></table></div>"
},
"entry" : [
{
🔗 "reference" : "Observation/TransurethralEnucleationMacroscopicGrouper"
}
]
},
{
"title" : "Diagnostische Schlussfolgerung",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "22637-3",
"display" : "Pathology report final diagnosis Narrative"
}
]
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h3>Mikroskopie</h3><p>Azinäres Adenokarzinom der Prostata mit invasiven cribriformen Anteilen und intraduktalem Karzinom. Extensive Tumorinfiltration mit perineuralem und lymphovaskulärem Befall.</p><h3>Diagnostische Schlussfolgerung</h3><p>Gleason-Score 4+5=9, ISUP-Gradgruppe 5 (WHO 2016). Anteil Gleasonmuster 4/5: 90%. Tumorinfiltration ca. 60% des Prostatagewebes. Intraduktales Karzinom und invasive kribriforme Anteile nachgewiesen. Extraprostatische Ausbreitung, Samenblaseninvasion, lymphovaskuläre Invasion und perineurale Infiltration nachgewiesen.</p><table border=\"1\" cellpadding=\"4\" cellspacing=\"0\"><tbody><tr><td>Histologischer Typ</td><td>Azinäres Adenokarzinom mit invasiven kribriformen Anteilen (8140/3)</td></tr><tr><td>Gleason-Score</td><td>4+5=9</td></tr><tr><td>ISUP-Gradgruppe</td><td>5 (WHO 2016)</td></tr><tr><td>Tumoranteil</td><td>60%</td></tr><tr><td>Anteil Gleason 4/5</td><td>90%</td></tr><tr><td>Intraduktales Karzinom</td><td>Nachgewiesen</td></tr><tr><td>Invasives kribriformes Karzinom</td><td>Nachgewiesen</td></tr><tr><td>Extraprostatische Ausbreitung</td><td>Nachgewiesen</td></tr><tr><td>Samenblaseninfiltration</td><td>Nachgewiesen</td></tr><tr><td>Lymphovaskuläre Invasion</td><td>Nachgewiesen</td></tr><tr><td>Perineurale Infiltration</td><td>Nachgewiesen</td></tr></tbody></table><p><b>Diagnose:</b> Azinäres Adenokarzinom der Prostata (ICD-O 8140/3) – High-grade</p><p><b>Empfehlung:</b> Staging-Untersuchungen und interdisziplinäre Tumorkonferenz.</p></div>"
},
"entry" : [
{
🔗 "reference" : "Observation/TransurethralEnucleationDiagnosticConclusionGrouper"
}
]
}
]
}